| UniProt ID | NBR1_HUMAN | |
|---|---|---|
| UniProt AC | Q14596 | |
| Protein Name | Next to BRCA1 gene 1 protein | |
| Gene Name | NBR1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 966 | |
| Subcellular Localization | Cytoplasm . Cytoplasmic vesicle, autophagosome . Lysosome . Cytoplasm, myofibril, sarcomere, M line . In cardiac muscles localizes to the sarcomeric M line (By similarity). Is targeted to lysosomes for degradation (PubMed:19250911). | |
| Protein Description | Acts probably as a receptor for selective autophagosomal degradation of ubiquitinated targets.. | |
| Protein Sequence | MEPQVTLNVTFKNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYLDEENEEVSINSQGEYEEALKMAVKQGNQLQMQVHEGHHVVDEAPPPVVGAKRLAARAGKKPLAHYSSLVRVLGSDMKTPEDPAVQSFPLVPCDTDQPQDKPPDWFTSYLETFREQVVNETVEKLEQKLHEKLVLQNPSLGSCPSEVSMPTSEETLFLPENQFSWHIACNNCQRRIVGVRYQCSLCPSYNICEDCEAGPYGHDTNHVLLKLRRPVVGSSEPFCHSKYSTPRLPAALEQVRLQKQVDKNFLKAEKQRLRAEKKQRKAEVKELKKQLKLHRKIHLWNSIHGLQSPKSPLGRPESLLQSNTLMLPLQPCTSVMPMLSAAFVDENLPDGTHLQPGTKFIKHWRMKNTGNVKWSADTKLKFMWGNLTLASTEKKDVLVPCLKAGHVGVVSVEFIAPALEGTYTSHWRLSHKGQQFGPRVWCSIIVDPFPSEESPDNIEKGMISSSKTDDLTCQQEETFLLAKEERQLGEVTEQTEGTAACIPQKAKNVASERELYIPSVDLLTAQDLLSFELLDINIVQELERVPHNTPVDVTPCMSPLPHDSPLIEKPGLGQIEEENEGAGFKALPDSMVSVKRKAENIASVEEAEEDLSGTQFVCETVIRSLTLDAAPDHNPPCRQKSLQMTFALPEGPLGNEKEEIIHIAEEEAVMEEEEDEEDEEEEDELKDEVQSQSSASSEDYIIILPECFDTSRPLGDSMYSSALSQPGLERGAEGKPGVEAGQEPAEAGERLPGGENQPQEHSISDILTTSQTLETVPLIPEVVELPPSLPRSSPCVHHHGSPGVDLPVTIPEVSSVPDQIRGEPRGSSGLVNSRQKSYDHSRHHHGSSIAGGLVKGALSVAASAYKALFAGPPVTAQPIISEDQTAALMAHLFEMGFCDRQLNLRLLKKHNYNILQVVTELLQLNNNDWYSQRY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 60 | Phosphorylation | NEEVSINSQGEYEEA CCEEEECCCCHHHHH | 37.58 | - | |
| 100 | Ubiquitination | PPPVVGAKRLAARAG CCCCCCHHHHHHHHC | 41.85 | - | |
| 108 | Ubiquitination | RLAARAGKKPLAHYS HHHHHHCCCCCCCHH | 50.67 | - | |
| 109 | Ubiquitination | LAARAGKKPLAHYSS HHHHHCCCCCCCHHH | 44.33 | - | |
| 114 | Phosphorylation | GKKPLAHYSSLVRVL CCCCCCCHHHHHHHH | 8.37 | 21945579 | |
| 115 | Phosphorylation | KKPLAHYSSLVRVLG CCCCCCHHHHHHHHC | 13.82 | 21945579 | |
| 116 | Phosphorylation | KPLAHYSSLVRVLGS CCCCCHHHHHHHHCC | 24.58 | 21945579 | |
| 123 | Phosphorylation | SLVRVLGSDMKTPED HHHHHHCCCCCCCCC | 30.30 | 20068231 | |
| 126 | Ubiquitination | RVLGSDMKTPEDPAV HHHCCCCCCCCCCCC | 66.95 | - | |
| 149 | Ubiquitination | DTDQPQDKPPDWFTS CCCCCCCCCCCHHHH | 53.88 | - | |
| 149 | Sumoylation | DTDQPQDKPPDWFTS CCCCCCCCCCCHHHH | 53.88 | - | |
| 172 | Ubiquitination | VVNETVEKLEQKLHE HHHHHHHHHHHHHHH | 53.65 | - | |
| 176 | Ubiquitination | TVEKLEQKLHEKLVL HHHHHHHHHHHHHHC | 42.30 | - | |
| 193 | Phosphorylation | PSLGSCPSEVSMPTS CCCCCCCCCCCCCCC | 55.76 | 24275569 | |
| 273 | Phosphorylation | SSEPFCHSKYSTPRL CCCCCCCCCCCCCCH | 34.17 | 28555341 | |
| 274 | Ubiquitination | SEPFCHSKYSTPRLP CCCCCCCCCCCCCHH | 21.39 | - | |
| 275 | Phosphorylation | EPFCHSKYSTPRLPA CCCCCCCCCCCCHHH | 22.31 | 21712546 | |
| 276 | Phosphorylation | PFCHSKYSTPRLPAA CCCCCCCCCCCHHHH | 35.35 | 20068231 | |
| 277 | Phosphorylation | FCHSKYSTPRLPAAL CCCCCCCCCCHHHHH | 14.88 | 20068231 | |
| 291 | Ubiquitination | LEQVRLQKQVDKNFL HHHHHHHHHHCHHHH | 57.81 | - | |
| 295 | Ubiquitination | RLQKQVDKNFLKAEK HHHHHHCHHHHHHHH | 51.23 | - | |
| 299 | Ubiquitination | QVDKNFLKAEKQRLR HHCHHHHHHHHHHHH | 50.81 | - | |
| 313 | Acetylation | RAEKKQRKAEVKELK HHHHHHHHHHHHHHH | 46.54 | 156467 | |
| 317 | Ubiquitination | KQRKAEVKELKKQLK HHHHHHHHHHHHHHH | 49.16 | - | |
| 320 | Ubiquitination | KAEVKELKKQLKLHR HHHHHHHHHHHHHHH | 39.29 | - | |
| 328 | Ubiquitination | KQLKLHRKIHLWNSI HHHHHHHHHHHHHHH | 24.59 | - | |
| 334 | Phosphorylation | RKIHLWNSIHGLQSP HHHHHHHHHCCCCCC | 12.36 | 28450419 | |
| 340 | Phosphorylation | NSIHGLQSPKSPLGR HHHCCCCCCCCCCCC | 39.06 | 20068231 | |
| 394 | Ubiquitination | QPGTKFIKHWRMKNT CCCCCEEEEEECCCC | 40.00 | - | |
| 399 | Ubiquitination | FIKHWRMKNTGNVKW EEEEEECCCCCCCCC | 42.66 | - | |
| 405 | Ubiquitination | MKNTGNVKWSADTKL CCCCCCCCCCCCCCE | 39.16 | - | |
| 411 | Ubiquitination | VKWSADTKLKFMWGN CCCCCCCCEEEEEEC | 50.67 | - | |
| 426 | Ubiquitination | LTLASTEKKDVLVPC EEEEECCCCCCCHHC | 55.13 | - | |
| 427 | Ubiquitination | TLASTEKKDVLVPCL EEEECCCCCCCHHCC | 47.00 | - | |
| 464 (in isoform 1) | Ubiquitination | - | 55.85 | 21906983 | |
| 464 (in isoform 2) | Ubiquitination | - | 55.85 | 21906983 | |
| 464 | Ubiquitination | SHWRLSHKGQQFGPR CCEEECCCCCCCCCE | 55.85 | 21906983 | |
| 483 | Phosphorylation | IIVDPFPSEESPDNI EEEECCCCCCCCCCC | 55.14 | 28348404 | |
| 486 | Phosphorylation | DPFPSEESPDNIEKG ECCCCCCCCCCCHHC | 33.24 | 21712546 | |
| 492 | Ubiquitination | ESPDNIEKGMISSSK CCCCCCHHCCCCCCC | 50.40 | - | |
| 499 | Ubiquitination | KGMISSSKTDDLTCQ HCCCCCCCCCCCCCC | 58.90 | - | |
| 515 | Ubiquitination | EETFLLAKEERQLGE HHHHHHHHHHHHHCC | 61.14 | - | |
| 537 (in isoform 2) | Ubiquitination | - | 56.84 | 21906983 | |
| 537 (in isoform 1) | Ubiquitination | - | 56.84 | 21906983 | |
| 537 | Ubiquitination | TAACIPQKAKNVASE CCCCCCHHHHCCCCC | 56.84 | 21906983 | |
| 537 | Acetylation | TAACIPQKAKNVASE CCCCCCHHHHCCCCC | 56.84 | 26051181 | |
| 539 | Ubiquitination | ACIPQKAKNVASERE CCCCHHHHCCCCCCC | 60.02 | - | |
| 581 | Phosphorylation | LERVPHNTPVDVTPC HCCCCCCCCCCCCCC | 22.96 | 29255136 | |
| 586 | Phosphorylation | HNTPVDVTPCMSPLP CCCCCCCCCCCCCCC | 13.30 | 29255136 | |
| 590 | Phosphorylation | VDVTPCMSPLPHDSP CCCCCCCCCCCCCCC | 29.96 | 25849741 | |
| 596 | Phosphorylation | MSPLPHDSPLIEKPG CCCCCCCCCCCCCCC | 20.69 | 29255136 | |
| 601 | Ubiquitination | HDSPLIEKPGLGQIE CCCCCCCCCCCCCCC | 37.07 | - | |
| 617 | Ubiquitination | ENEGAGFKALPDSMV CCCCCCCCCCCHHHH | 48.36 | - | |
| 622 | Phosphorylation | GFKALPDSMVSVKRK CCCCCCHHHHHHHHH | 21.10 | 30266825 | |
| 625 | Phosphorylation | ALPDSMVSVKRKAEN CCCHHHHHHHHHHHH | 17.18 | 30266825 | |
| 627 | Ubiquitination | PDSMVSVKRKAENIA CHHHHHHHHHHHHCC | 40.45 | - | |
| 629 | Ubiquitination | SMVSVKRKAENIASV HHHHHHHHHHHCCCH | 55.10 | - | |
| 656 | Phosphorylation | VCETVIRSLTLDAAP HHHHHHHHCCCCCCC | 18.00 | 30266825 | |
| 658 | Phosphorylation | ETVIRSLTLDAAPDH HHHHHHCCCCCCCCC | 24.68 | 30266825 | |
| 672 | Ubiquitination | HNPPCRQKSLQMTFA CCCCCCCCCEEEEEE | 33.51 | - | |
| 673 | Phosphorylation | NPPCRQKSLQMTFAL CCCCCCCCEEEEEEC | 18.59 | 28355574 | |
| 677 | Phosphorylation | RQKSLQMTFALPEGP CCCCEEEEEECCCCC | 7.87 | 22777824 | |
| 767 (in isoform 1) | Ubiquitination | - | 30.06 | 21906983 | |
| 767 (in isoform 2) | Ubiquitination | - | 30.06 | 21906983 | |
| 767 | Ubiquitination | LERGAEGKPGVEAGQ CCCCCCCCCCCCCCC | 30.06 | 21906983 | |
| 824 | Phosphorylation | LPPSLPRSSPCVHHH CCCCCCCCCCCCCCC | 36.37 | 25159151 | |
| 825 | Phosphorylation | PPSLPRSSPCVHHHG CCCCCCCCCCCCCCC | 24.49 | 25159151 | |
| 833 | Phosphorylation | PCVHHHGSPGVDLPV CCCCCCCCCCCCCCE | 17.71 | 27174698 | |
| 841 | Phosphorylation | PGVDLPVTIPEVSSV CCCCCCEECCCCCCC | 28.95 | 27174698 | |
| 846 | Phosphorylation | PVTIPEVSSVPDQIR CEECCCCCCCCCHHC | 24.77 | 27174698 | |
| 847 | Phosphorylation | VTIPEVSSVPDQIRG EECCCCCCCCCHHCC | 42.73 | 27174698 | |
| 887 | Ubiquitination | SIAGGLVKGALSVAA CHHHHHHHHHHHHHH | 43.43 | - | |
| 891 | Phosphorylation | GLVKGALSVAASAYK HHHHHHHHHHHHHHH | 14.80 | 28555341 | |
| 898 | Ubiquitination | SVAASAYKALFAGPP HHHHHHHHHHHCCCC | 38.03 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NBR1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NBR1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...